Corporations Regulations 2001

General

1

The person’s name

2

Each position held by the person in the financial year

3

If the person has held a position mentioned in item 2 for less than the whole financial year

(a) The date on which the person began holding the position

(b) The date (if any) on which the person ceased to hold the position

4

If there has been a change in the chief executive officer or a director of the entity during the period:

(a) starting immediately after the reporting date; and

(b) ending immediately before the date on which the financial report is authorised for issue

(a) The name of each person involved in the change

(b) The position involved

(c) The date on which the change occurred

5

If a person (other than a director or chief executive officer) has retired during the period:

(a) starting immediately after the reporting date; and

(b) ending immediately before the date on which the financial report is authorised for issue

(a) The person’s name

(b) The position involved

(c) The date on which the retirement took effect

Payments and benefits

6

Note: See subregulation (2).

The person’s short‑term employee benefits, divided into at least the following components:

(a) cash salary, fees and short‑term compensated absences;

(b) short‑term cash profit‑sharing and other bonuses;

(c) non‑monetary benefits;

(d) other short‑term employee benefits

7

Note: See subregulation (2).

The person’s post‑employment benefits, divided into at least the following components:

(a) pension and superannuation benefits;

(b) other post‑employment benefits

8

Note: See subregulation (2).

The person’s long‑term employee benefits other than benefits mentioned in items 6 and 7, separately identifying any amount attributable to a long‑term incentive plan

9

Note: See subregulation (2).

The person’s termination benefits

10

For any position the person started to hold during the financial year

Payments (if any) made to the person, before the person started to hold the position, as part of the consideration for the person agreeing to hold the position, including:

(a) the monetary value of the payment; and

(b) the date of the payment

11

Note: See subregulation (2).

Share‑based payments made to the person, divided into at least the following components:

(a) equity‑settled share‑based payment transactions, showing separately:

(i) shares and units; and

(ii) options and rights;

(b) cash‑settled share‑based payment transactions;

(c) all other forms of share‑based payment compensation (including hybrids)

Compensation

12

For each grant of a cash bonus, performance‑related bonus or share‑based payment compensation benefit made to a person, whether part of a specific contract for services or not

The terms and conditions of each grant affecting compensation in the reporting period or a future reporting period, including the following:

(a) the grant date;

(b) the nature of the compensation granted;

(c) the service and performance criteria used to determine the amount of compensation;

(d) if there has been any alteration of the terms or conditions of the grant since the grant date—the date, details and effect of each alteration;

(e) the percentage of the bonus or grant for the financial year that was paid to the person, or that vested in the person, in the financial year;

(f) the percentage of the bonus or grant for the financial year that was forfeited by the person (because the person did not meet the service and performance criteria for the bonus or grant) in the financial year;

(g) the financial years, after the financial year to which the report relates, for which the bonus or grant will be payable if the person meets the service and performance criteria for the bonus or grant;

(h) estimates of the maximum and minimum possible total value of the bonus or grant (other than option grants) for financial years after the financial year to which the report relates

13

For each contract for services between a person and the disclosing entity (or any of its subsidiaries)

Any further explanation that is necessary in addition to those prescribed in paragraph 300A(1)(ba) of the Act and item 12 to provide an understanding of:

(a) how the amount of compensation in the current reporting period was determined; and

(b) how the terms of the contract affect compensation in future periods

14

If the terms of share‑based payment transactions (including options or rights) granted as compensation to key management personnel have been altered or modified by the disclosing entity or any of its subsidiaries during the reporting period

(a) The date of the alteration

(b) The market price of the underlying equity instrument at the date of the alteration

(c) The terms of the grant of compensation immediately before the alteration, including:

(i) the number and class of the underlying equity instruments, exercise price; and

(ii) the time remaining until expiry; and

(iii) each other condition in the terms that affects the vesting or exercise of an option or other right

(d) The new terms

(e) The difference between:

(i) the total of the fair value of the options or other rights affected by the alteration immediately before the alteration; and

(ii) the total of the fair value of the options or other rights immediately after the alteration

15

If options and rights over an equity instrument issued or issuable by the disclosing entity or any of its subsidiaries have been provided as compensation to a person during the reporting period

Note: See subregulation (3).

(a) The number of options and the number of rights that:

(i) have been granted; and

(ii) have vested;

 during the reporting period

(b) The terms and conditions of each grant made during the reporting period, including:

(i) the fair value per option or right at grant date; and

(ii) the exercise price per share or unit; and

(iii) the amount, if any, paid or payable by the recipient; and

(iv) the expiry date; and

(v) the date or dates when the options or rights may be exercised; and

(vi) a summary of the service and performance criteria that must be met before the beneficial interest vests in the person

16

If an equity instrument that is issued or issuable by the disclosing entity or any of its subsidiaries has been provided as a result of the exercise during the reporting period of options and rights that have been granted as compensation to a person

Note: See subregulation (3).

(a) The number of equity instruments

(b) If the number of options or rights exercised differs from the number of equity instruments disclosed under paragraph (a)—the number of options or rights exercised

(c) The amount paid per instrument

(d) The amount unpaid per instrument

Remuneration disclosure

17

For an option or right over equity instruments:

(a) issued or issuable by the disclosing entity or any of its subsidiaries; and

(b) held, whether directly, indirectly or beneficially, by any of the following:

(i) each key management person;

(ii) a close member of the family of that person;

(iii) an entity over which the person or the family member has, either directly or indirectly, control, joint control or significant influence

The number of each of the following:

(a) options and rights held at the start of the reporting period;

(b) options and rights granted during the reporting period as compensation;

(c) options and rights exercised during the reporting period;

(d) options and rights resulting from any other change during the reporting period;

(e) options and rights held at the end of the reporting period;

(f) options and rights vested at the end of the reporting period;

(g) options and rights vested and exercisable at the end of the reporting period;

(h) options and rights vested and unexercisable at the end of the reporting period

18

For an equity instrument (other than an option or a right):

(a) issued or issuable by the disclosing entity or any of its subsidiaries; and

(b) held, whether directly, indirectly or beneficially, by any of the following:

(i) each key management person;

(ii) a close member of the family of that person;

(iii) an entity over which the person or the family member has, either directly or indirectly, control, joint control or significant influence

The number of each of the following:

(a) equity instruments held at the start of the reporting period;

(b) equity instruments granted during the reporting period as compensation;

(c) equity instruments received during the reporting period on the exercise of an option or right;

(d) equity instruments resulting from any other change during the reporting period;

(e) equity instruments held at the end of the reporting period;

(f) equity instruments if included in the number disclosed under paragraph (e), held nominally at the end of the reporting period

19

For a transaction (other than share‑based payment compensation) that:

(a) involves an equity instrument issued or issuable by the disclosing entity or any of its subsidiaries; and

(b) has occurred, during the reporting period, between the disclosing entity or any of its subsidiaries and any of the following:

(i) a key management person;

(ii) a close member of the family of that person;

(iii) an entity over which the person or the family member has, either directly or indirectly, control, joint control or significant influence;

if the terms or conditions of the transaction were more favourable than those that it is reasonable to expect the entity would adopt if dealing at arms‑length with an unrelated person

(a) The nature of each different type of transaction

(b) For each transaction, the terms and conditions of the transaction

20

For the aggregate of loans made, guaranteed or secured, directly or indirectly, by the disclosing entity and any of its subsidiaries, in the reporting period in relation to:

(a) all key management personnel; and

(b) close members of the family of a member of the key management personnel; and

(c) an entity over which any of the persons mentioned in paragraphs (a) and (b) have, directly or indirectly, control, joint control or significant influence

(a) The amount outstanding at the start of the reporting period

(b) The amount of interest paid and payable in the reporting period to the disclosing entity or to any of the entity’s subsidiaries

(c) The difference between the amount disclosed under paragraph (b) and the amount of interest that would have been charged on an arms‑length basis

(d) Each write‑down and each allowance for doubtful receivables recognised by the disclosing entity or by any of the entity’s subsidiaries

(e) The amount outstanding at the end of the reporting period

(f) The number of key management personnel included in the group aggregate at the end of the reporting period

(g) A summary of the terms and conditions of the loans

21

If the aggregate of loans made, guaranteed or secured, directly or indirectly, by the disclosing entity and any of its subsidiaries, in the reporting period in relation to:

(a) a particular key management person; and

(b) close members of the family of the key management person; and

(c) an entity over which any of the persons mentioned in paragraphs (a) and (b) has, directly or indirectly, control, joint control or significant influence;

is greater than $100 000

(a) The amount outstanding at the start of the reporting period

(b) The amount of interest paid and payable in the reporting period to the disclosing entity or to any of the entity’s subsidiaries

(c) The difference between the amount disclosed under paragraph (b) and the amount of interest that would have been charged on an arms‑length basis

(d) Each write‑down and each allowance for doubtful receivables recognised by the disclosing entity or by any of the entity’s subsidiaries

(e) The amount outstanding at the end of the reporting period

(f) The highest amount of the key management person’s indebtedness during the reporting period

(g) A summary of the terms and conditions of the loans

22

For a transaction during the reporting period between the disclosing entity, or any of its subsidiaries, and a key management person, a close member of the family of that person, or an entity over which the key management person or the family member has, directly or indirectly, control, joint control or significant influence, other than a transaction mentioned in item 19, 20 or 21 or subregulation (3B)

(a) Each type of transaction of a different nature

(b) The terms and conditions of each type of transaction or, if there are different categories of terms and conditions within a type of transaction, the terms and conditions of each category of transaction

(c) For each type of transaction or, if there are different categories of terms and conditions within a type of transaction, for each category of transaction:

(i) the names of the persons involved in the transaction; and

(ii) the aggregate amount recognised

23

For each aggregate amount disclosed under item 22

(a) The total of amounts recognised as revenue, separately identifying, if applicable, the total amounts recognised as:

(i) interest revenue; or

(ii) dividend revenue

(b) The total of amounts recognised as expense, separately identifying, if applicable, the total amounts recognised as:

(i) interest expense; or

(ii) write‑downs of receivables and allowances made for doubtful receivables

(c) Any further disclosures necessary to provide an understanding of the effects of the transactions on the financial statements prepared in accordance with Australian Accounting Standards

24

For each transaction identified under item 22

(a) The total of all assets, classified into current and non‑current assets, and, if applicable, any allowance for doubtful receivables at the end of the reporting period

(b) The total of all liabilities, classified into current and non‑current liabilities